Ensign Peak Advisors, Inc Amgen Inc Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Amgen Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 267,065 shares of AMGN stock, worth $71.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

267,065

Previous 268,960 0.7%

Holding current value

$71.2 Million

Previous $84 Million 2.4%

% of portfolio

0.15%

Previous 0.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $586,275 - $639,335	-1,895 Reduced 0.7%	267,065 $86.1 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $1.05 Million - $1.28 Million	-4,002 Reduced 1.47%	268,960 $84 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $105 Million - $127 Million	-391,393 Reduced 58.91%	272,962 $77.6 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $24.6 Million - $27.7 Million	-96,069 Reduced 12.63%	664,355 $191 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $84.2 Million - $104 Million	384,955 Added 102.53%	760,424 $204 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $4.08 Million - $4.82 Million	-19,028 Reduced 4.82%	375,469 $83.4 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $24.6 Million - $30 Million	-108,923 Reduced 21.64%	394,497 $95.4 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $946,810 - $1.2 Million	-4,134 Reduced 0.81%	503,420 $132 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.47 Million - $1.65 Million	-6,530 Reduced 1.27%	507,554 $114 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $64 Million - $71.2 Million	277,374 Added 117.18%	514,084 $125 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $13 Million - $14.3 Million	59,155 Added 33.32%	236,710 $57.2 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $19.7 Million - $22.5 Million	98,853 Added 125.6%	177,555 $39.9 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.52 Million - $1.78 Million	-7,155 Reduced 8.33%	78,702 $16.7 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $211,389 - $234,521	-905 Reduced 1.04%	85,857 $20.9 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $22.1 Million - $25.7 Million	-99,457 Reduced 53.41%	86,762 $21.6 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $20.8 Million - $24.8 Million	-96,353 Reduced 34.1%	186,219 $42.8 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $3.63 Million - $4.04 Million	15,465 Added 5.79%	282,572 $71.8 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $13.7 Million - $16.9 Million	-69,417 Reduced 20.63%	267,107 $63 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $7.02 Million - $9.31 Million	38,534 Added 12.93%	336,524 $68.2 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $56.4 Million - $72.5 Million	297,990 New	297,990 $71.8 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $143B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Amgen Inc Transaction History